With recent technology and ongoing advances in the scientific field, methods have been developed to synthesize complex peptide preparations from the extracts of several different tissues
In the current clinical scenario, Tirzepatide, a dual agonist of glucagon like peptide 1 and glucose dependent insulinotropic polypeptide receptors, has been shown to reduce the apnea hypopnea index by up to nearly two thirds in patients with obesity
Our results showed that adenosine levels were decreased in obese mice, which were ameliorated after semaglutide administration
The treatment, using ultrapure hyaluronic acid, deeply hydrated the skin while reducing dynamic wrinkles, effectively combating facial aging
1 Discontinuation rates Clinical trial data suggest a higher proportion of participants discontinue liraglutide due to side effects compared with tirzepatide